The market fluctuated and adjusted throughout the day, with the ChiNext Index leading the decline, and the Shanghai Stock Exchange Index gaining and losing 3,100 points. On the market, pharmaceutical stocks collectively rose sharply, and traditional Chinese medicine stocks set off a daily limit trend, with 10 stocks including Dali Pharmaceutical, Zhongsheng Pharmaceutical, and Yiling Pharmaceutical exceeding their daily limit. The real estate sector continued last Friday's gains, with Gemdale Group, Xincheng Holdings, Xinhualian, etc. reaching their daily limit. Xinchuang concept stocks changed in the afternoon, with 263, Xinyada, Weichuang shares, etc. hitting their daily limit, and Jingyeda hitting a record high in the session. In terms of decline, track stocks fell into adjustment, with photovoltaics, lithium batteries and other directions leading the decline, and Lanxiao Technology, Junda Shares, etc. falling sharply. Generally speaking, individual stocks fell more than they rose, with more than 2,800 stocks falling in the two cities. The turnover of Shanghai and Shenzhen stock markets today was 1.0763 billion, a decrease of 146.8 billion from the previous trading day. In terms of sectors, sectors such as traditional Chinese medicine, pharmaceutical business, COVID-19 treatment, and ophthalmology were among the top gainers, while sectors such as airports, supply and marketing cooperatives, TOPCON batteries, and salt lake lithium extraction were among the top losers.
In terms of sectors
Today’s hot spots revolve around the two major directions of medicine and real estate. First, focus on the big pharmaceutical sector. It can be seen that traditional Chinese medicine, new crown treatment, and pharmaceutical business all have the largest increases. On November 11, 2022, the State Council issued the "Notice on Further Optimizing the Prevention and Control Measures for the New Coronavirus Epidemic and Doing a Scientific and Accurate Prevention and Control Work" (new "20 Articles"), which mainly emphasizes the important tool attributes of testing, vaccines, and drugs, and strengthens medical treatment. Resource construction. The latest epidemic prevention notice provides relevant explanations on the construction of medical resources, COVID-19 vaccination coverage, COVID-19 drug reserves, and protection of key groups, emphasizing the importance of epidemic prevention tools. Guosheng Securities believes that the follow-up anti-epidemic tool kit will still be a very important strategic component. The market may intensify the hype of self-driven anti-epidemic consumption. In the future, we will focus on pharmacies, fever, cough and anti-inflammatory OTC, ventilator and other branches. field. In addition, in the post-epidemic era, the expansion of large hospitals and the quality improvement and transformation of grassroots hospitals will be accelerated, and there will be new opportunities for medical devices and equipment to increase.
From a market perspective, the strong recovery in the direction of COVID-19 drugs today may indicate that the current COVID-19 treatment concept is still the most recognized direction for funds. Therefore, after a large number of funds change hands, The pharmaceutical sector is still expected to remain active. However, it should be noted that the recent signs of mutual competition between short-term pharmaceutical funds may lead to further intensification of the recent swings of related stocks. Therefore, from the perspective of capital security, the risk-benefit ratio of pursuing the direction of new coronavirus drugs at this time may be relatively low. If you still want to participate in the pharmaceutical direction, you can focus on self-driven anti-epidemic consumption, which is an extended branch of the new coronavirus drug concept and is still at a relatively low level.
Let’s pay attention to the hot real estate and its industrial chain on the other side of today’s market, including Xinhualian, Bunny, Zhongtian Services, Zhongtian Fine Decoration, Yuetai Co., Ltd., Tiandiyuan, and Xincheng Holdings. In terms of news, Bank of China Securities believes that this bond financing support tool clearly states that it will strengthen support for private real estate. If the issuance of 250 billion is completed, it may effectively alleviate the liquidity pressure of large private real estate companies, significantly restore and stabilize real estate expectations, and have a high proportion of banks, especially real estate. The benefits of joint-stock banks are outstanding. In addition, under the background of continued efforts to stabilize growth and better-than-expected policies, excessively pessimistic expectations for the economy may be restored. There may still be room for upside in real estate, its industrial chain, and finance. However, judging from today's intraday trend, the market divergence is still obvious, and the short-term capital game is still fierce. Therefore, investors who have not made a first-hand layout before may wish to wait patiently for the buying point on the right after the real estate direction has diverged to consolidate before entering the market and consider more. To be safe.
In terms of individual stocks
Today’s track stocks showed a more obvious drag on the market, among which Xinyuan’s weight dropped the most. For example, the inverter leader Sungrow Power fell by more than 7, and the lithium battery leader Ningde Times fell by more than 4, Yiwei Lithium fell by more than 6, while Ganfeng Lithium and Tianqi Lithium, the two leading lithium mines, both fell by more than 4. The continued weakening of track stocks is mainly limited by the market style. Whether it is Xinchuang, pharmaceuticals or real estate in the past, the rising logic behind them is policy-driven and combined with deep decline and recovery. And behind this rising logic It reflects a more obvious short-term gaming style. More intuitively, the recent money-making effect is mainly concentrated in the high popularity of the main direction.
Therefore, judging from the current market style, we should still pay attention to small and medium-sized market capitalization stocks in the subsequent selection of individual stocks.
From the short-term market point of view, although the height of today's market plummeted to 3 consecutive boards. However, the better thing is that the high-level leading stocks in the main direction have ushered in a strong return of funds. Among them, the most iconic Zhongsheng Pharmaceutical has once again reached its daily limit. Yiling Pharmaceutical, Guangshengtang, Xinhua Pharmaceutical and other stocks have also completed their rebounds one after another. Bao, as for the direction of Xinchuang, Jingyeda rose by more than 6 and hit a new high in share price, while 263, Xinyada, Weichuang shares, etc. hit their daily limit. Therefore, before the collective ebb of the above-mentioned high popularity standards, the main line sector is expected to continue to be active. In terms of short-term arbitrage, we can pay attention to the opportunities of low-level compensatory gains in related sectors.
Analysis of the market outlook
As of the close, the Shanghai Stock Exchange Index fell 0.13, the Shenzhen Component Index fell 0.24, and the ChiNext Index fell 1.25. Northbound funds made a net purchase of 16.602 billion yuan throughout the day, the largest single-day net purchase during the year, of which the Shanghai Stock Connect net purchase was 8.303 billion yuan and the Shenzhen Stock Connect net purchase was 8.299 billion yuan.
Today's market continues to be relatively divided. Among them, popular directions such as pharmaceuticals, real estate, and Xinchuang continue to strengthen, while track stocks continue to be weak last week. After the Shanghai Composite Index continued to fluctuate a lot, it may face a choice of direction. It should be noted that, with the largest single-day net buying by foreign investors during the year, driven by the two major weights of medicine and real estate, the index has still failed to form an obvious positive shock, which shows that the current selling pressure in the market cannot be underestimated. Once the Shanghai Composite Index effectively falls below last Friday's low of 3070 tomorrow, it may return to consolidation in the short term, and it will need to experience a period of shock in the medium term to build a bottom.
CITIC Securities pointed out that the three major factors of adjusting the direction of the epidemic prevention policy, the expected inflection point of external liquidity, and the improvement of geographical disturbances have been clearly understood, respectively improving fundamentals, valuation and risk appetite, and the comprehensive recovery of A-share market has been established. , the market is easy to rise but difficult to fall. It is still in the first half of the policy-driven period. The focus of trading is expected to switch from the game of policy expectations to the game of policy effects. It is recommended to increase the balanced allocation of positions. It is recommended to focus on precise prevention and control and real estate where policy benefits are more obvious. There are three main lines: industrial chain and global liquidity turning point.
In terms of individual stocks, 2,004 stocks rose, 822 fewer than the previous trading day. Excluding ST shares and unlisted new stocks, there were 64 companies at the daily limit, 4 more than the previous trading day; 34 companies on the explosive board, 34 less than the previous trading day; GEM stocks/science and technology innovation board stocks at the daily limit of 7 5 stocks increased from the previous trading day; 0 stocks fell to the limit, the same as the previous trading day.
In terms of sentiment, as the index fell into consolidation again, today's short-term sentiment indicators have always fluctuated around the 0 axis to the downturn zone.
Market News Focus
1. National Energy Administration: Currently, we are speeding up the review of the third batch of large-scale wind power and photovoltaic base projects
Financial Associated Press, November 14 According to news, Dong Wancheng, deputy director of the Development Planning Department of the National Energy Administration, introduced at the fourth quarter online press conference on the 14th that the first batch of large-scale wind power and photovoltaic bases have all started construction, the second batch of projects are starting one after another, and the third batch is currently being promoted. Project review.
2. The Social Credit System Construction Law publicly solicits opinions and plans to increase the punishment for malicious evasion of bank debts, insider trading and other illegal and untrustworthy behaviors
Financial Associated Press November 14 According to news, the National Development and Reform Commission and the People's Bank of China, together with member units of the inter-ministerial joint conference on the construction of the social credit system and other relevant departments (units), have studied and drafted the "Law of the People's Republic of China on the Construction of the Social Credit System (Draft for Solicitation of Public Opinions)" )" is now open to the public for comments. The opinions are clear that administrative agencies should strengthen the construction of government integrity in the field of investment promotion, introduce preferential policies in accordance with laws and regulations, and strictly fulfill relevant commitments. Competent departments in the financial sector should increase efforts to crack down on financial fraud, malicious evasion of bank debts, insider trading, production and sale of fake insurance policies, fraudulent insurance and compensation claims, disclosure of false information, illegal fund-raising, evasion and evasion of foreign exchange, telecommunications and network fraud, and related crimes. The intensity of punishment for illegal and untrustworthy behavior.